NCT06835348View on ClinicalTrials.gov

An Observational, Multicenter Study Evaluating the Safety of ReAl-lifePertuzumab and Trastuzumab Fixed Dose Combination: the RAPID Study

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

November 29, 2024

Study Completion Date

November 29, 2024

Conditions

Breast Cancer

Trial Locations (7)

33081

Irccs - Centro Riferimento Oncologico (C.R.O.) Di Aviano, Aviano

80040

"ASL Napoli 3 sud - Stabilimento di Pollena Cav. R. Apicella", Pollena Trocchia

80131

"Istituto Nazionale Tumori Fondazione G. Pascale", Naples

81100

"A.O.R.N. Caserta Sant'Anna e San Sebastiano", Caserta

83100

A.O.R.N. San Giuseppe Moscati, Avellino

00144

IRCCS Istituto Nazionale Tumori Regina Elena, Rome

Unknown

Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome

All Listed Sponsors

lead

Fondazione Oncotech

OTHER

NCT06835348 - An Observational, Multicenter Study Evaluating the Safety of ReAl-lifePertuzumab and Trastuzumab Fixed Dose Combination: the RAPID Study | Biotech Hunter | Biotech Hunter